We describe a case of encephalomyelitis mimicking multiple sclerosis associated with chronic graft-versushost disease (GVHD) 
Introduction

Bone marrow transplantation (BMT) recipients are at high risk for neurological complications, including infection, metabolic abnormalities, drug toxicity, cerebrovascular events, posterior reversible encephalopathy syndrome (PRES), Epstein-Barr virus-associated lymphoproliferative disease (EBV-LPD), and relapse of malignant disease in the central nervous system (CNS) (1). Graft-versus-host disease (GVHD) is a systemic complication after BMT mediated by donor T cells targeting the skin, gastrointestinal tract, and liver. Involvement of other organ systems has been observed, but effects on the CNS are rare and controversial (2)
.
F i g u r e 2 . T 2 -we i g h t e d MRI o f t h e b r a i n r e v e a l s mu l t i p l e wh i t e ma t t e r l e s i o n s .
F i g u r e 3 . S p i n a l MRI r e v e a l s a h i g h i n t e n s i t y l e s i o n o f t h e t h o r a c i c s p i n a l c o r d . marrow cells was maintained, as determined by variable number of tandem repeat analysis. At this time, she was diagnosed with chronic GVHD.
Seven months after transplantation, the patient developed blurred vision in the right eye and was diagnosed with optic neuritis after fundus examination revealed optic nerve head edema (Fig. 1) (Fig. 2) and in the thoracic spine (Fig. 3) (Fig. 4) . Other manifestations of chronic GVHD also achieved remission. However, she developed weakness and numbness of
F i g u r e 4 . MRI o f t h e b r a i n a f t e r i mmu n o s u p p r e s s i v e t h e r a p y s h o ws i mp r o v e me n t o f wh i t e ma t t e r l e s i o n s . the upper and lower limbs again after methylprednisolone was tapered off, even though a therapeutic dose of CyA was administered at that time. Spinal MRI revealed new lesions of the cervical spine. The patient was again treated with methylprednisolone pulse therapy, and her neurological symptoms and radiological lesions of the cervical spine improved (Fig. 1). Improved neurological symptoms remained stable two years after transplantation, despite tapering of the methylprednisolone dose to 0.5 mg/kg.
Discussion
Although GVHD commonly affects the skin, gastrointestinal tract, liver, and hematopoietic system, recent reports have described patients with neurologic manifestations associated with GVHD (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) . Animal studies support the possibility of the brain being a target organ for GVHD (15) 
, however, CNS-GVHD remains controversial. CNS-GVHD may be properly diagnosed only if there is no evidence of other diseases with overlapping features and if radiographic characteristics of CNS involvement, response to immunosuppressive therapy, and T cell infiltration according to histological evaluation are observed (2). In the present case, negative evaluation for infection, multiple radiological le-
